[go: up one dir, main page]

HK1223580B - Injector for administering a liquid or pasty substance, in particular a drug - Google Patents

Injector for administering a liquid or pasty substance, in particular a drug Download PDF

Info

Publication number
HK1223580B
HK1223580B HK16111925.9A HK16111925A HK1223580B HK 1223580 B HK1223580 B HK 1223580B HK 16111925 A HK16111925 A HK 16111925A HK 1223580 B HK1223580 B HK 1223580B
Authority
HK
Hong Kong
Prior art keywords
syringe body
syringe
bottom wall
sleeve
envelope
Prior art date
Application number
HK16111925.9A
Other languages
Chinese (zh)
Other versions
HK1223580A1 (en
Inventor
比莱特.洛利安
萨沙.摩丝
Original Assignee
Elm塑胶股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102015002234.2A external-priority patent/DE102015002234A1/en
Priority claimed from EP15175696.2A external-priority patent/EP3028729B1/en
Application filed by Elm塑胶股份有限公司 filed Critical Elm塑胶股份有限公司
Publication of HK1223580A1 publication Critical patent/HK1223580A1/en
Publication of HK1223580B publication Critical patent/HK1223580B/en

Links

Description

用于给出液体或糊状物特别是药物的注射器A syringe used to administer liquids or pastes, especially medicines

技术领域Technical Field

本发明涉及一种用于给出第一或第二液体或糊状物的注射器。所述第一和/或第二液体或糊状物可特别是药物或含有一种或多种药物的物质。The present invention relates to a syringe for administering a first or second liquid or paste. The first and/or second liquid or paste may in particular be a drug or a substance containing one or more drugs.

发明内容Summary of the Invention

注射器包括外注射器本体,内注射器本体和活塞。在所述外注射器本体中形成用于第一液体或糊状物的第一体积。在所述内注射器本体中形成用于第二液体或糊状物的第二体积。在所述外注射器本体中,所述内注射器本体被纵向可移位地引导,因此其可以以旋转或非旋转的方式被纵向地引导。在所述内注射器本体中,活塞被纵向可移位地引导,因此其可以以旋转或非旋转的方式被纵向地引导。The syringe comprises an outer syringe body, an inner syringe body, and a piston. A first volume for a first liquid or paste is formed in the outer syringe body. A second volume for a second liquid or paste is formed in the inner syringe body. The inner syringe body is longitudinally displaceably guided in the outer syringe body, thereby allowing it to be longitudinally guided in a rotational or non-rotational manner. The piston is longitudinally displaceably guided in the inner syringe body, thereby allowing it to be longitudinally guided in a rotational or non-rotational manner.

在外注射器本体中,所述内注射器本体首先由活塞的移动而移动。第一液体或糊状物因此通过在所述外注射器本体的底壁区域中的一开口而被给出。当在外注射器本体中,所述内注射器本体已经到达其端部位置时,活塞可以在所述内注射器本体中移动。然后第二液体或糊状物可以被给出。In the outer syringe body, the inner syringe body is first moved by the movement of the piston. The first liquid or paste is thus dispensed through an opening in the bottom wall area of the outer syringe body. When the inner syringe body has reached its end position in the outer syringe body, the piston can be moved in the inner syringe body. Then the second liquid or paste can be dispensed.

根据权利要求1的前序部分的注射器,从DD 210 386B已知。A syringe according to the preamble of claim 1 is known from DD 210 386 B.

US2 157 503A公开了一种注射器,在其中可引入填充有液体的安瓿。可将含有药物制剂的片剂与安瓿中的液体进行混合。US Pat. No. 2,157,503 A discloses a syringe into which an ampoule filled with a liquid can be introduced. A tablet containing a pharmaceutical preparation can be mixed with the liquid in the ampoule.

血液去除及血液隔离系统从DE 695 31 774 T2已知,它包括注射器筒,主活塞和分配活塞。A blood removal and blood isolation system is known from DE 695 31 774 T2, which comprises a syringe barrel, a main piston and a dispensing piston.

本发明的目的是提供最初命名类型的改进注射器。It is an object of the present invention to provide an improved syringe of the type initially named.

根据本发明的所述目的通过权利要求1的特征实现。所述内注射器本体具有密封地接触所述外注射器本体的内壁的封套。所述封套特别是在所述内注射器本体在所述外注射器本体内移动的过程中密封地接触所述外注射器本体的内壁。当所述封套处于所述外注射器本体中的端部位置时,第二液体或糊状物可绕过其流动。从而确保了在给出第一液体或糊状物后也可以给出第二液体或糊状物。According to the present invention, this object is achieved by the features of claim 1. The inner syringe body comprises a sleeve that sealingly contacts the inner wall of the outer syringe body. The sleeve sealingly contacts the inner wall of the outer syringe body, particularly during movement of the inner syringe body within the outer syringe body. When the sleeve is in its end position within the outer syringe body, a second liquid or paste can flow around it. This ensures that the second liquid or paste can be dispensed after the first liquid or paste has been dispensed.

本发明的有益的进一步发展在从属权利要求中描述。Advantageous further developments of the invention are described in the dependent claims.

如果所述外注射器本体在其端部区域中具有一个或多个通道,是有益的。所述一个或多个通道可以位于所述外注射器本体的端部区域的内壁中。因为第二液体或糊状物流过一个或多个通道,当所述封套处于所述外注射器本体中的端部位置时,第二液体或糊状物可以从封套绕流。It is advantageous if the outer syringe body has one or more channels in its end region. The one or more channels can be located in the inner wall of the end region of the outer syringe body. Since the second liquid or paste flows through the one or more channels, the second liquid or paste can flow around the envelope when the envelope is in the end position in the outer syringe body.

所述封套优选在其下侧具有一个或多个凹槽。当所述封套处于所述外注射器本体中的端部位置时,第二液体或糊状物可流过这些凹槽。The sleeve preferably has one or more grooves on its underside through which the second liquid or paste can flow when the sleeve is in its end position in the outer syringe body.

另一有益的进一步发展的特征在于,所述封套以这样一种方式变形以便当其处于所述外注射器本体中的端部位置时,可绕过其流动。通道可经由所述封套的变形而形成,其在所述封套处于所述外注射器本体中的端部位置时被第二液体或糊状物流过。Another advantageous further development is characterized in that the envelope is deformed in such a way that a flow can flow around it when it is in the end position in the outer syringe body. A channel can be formed by the deformation of the envelope, which channel is flowed through by the second liquid or paste when the envelope is in the end position in the outer syringe body.

如果在所述外注射器本体的端部区域中提供腹板,是有益的。所述腹板优选地设置在所述外注射器本体的底壁中。所述封套可以被腹板变形。第二液体或糊状物可以流过腹板之间的区域。如果存在两个以上的腹板,是有益的。腹板优选均匀地分布在周边上。It is advantageous if webs are provided in the end region of the outer syringe body. These webs are preferably arranged in the bottom wall of the outer syringe body. The envelope can be deformed by the webs. The second liquid or paste can flow through the region between the webs. It is advantageous if there are more than two webs. The webs are preferably evenly distributed around the circumference.

根据本发明的注射器可以优选地用于将一种或多种液体和/或一种或多种糊剂和/或一种或多种药物给到动物的乳房内。因此,其可以特别地用作乳房注射器。The syringe according to the present invention can preferably be used to administer one or more liquids and/or one or more pastes and/or one or more medications into the udder of an animal. Thus, it can be used in particular as a udder syringe.

所述封套可释放地连接到所述内注射器本体是有益的。Advantageously, the envelope is releasably connectable to the inner syringe body.

然而,所述封套与所述内注射器本体形成为一体也是有益的。However, it may also be advantageous for the envelope to be formed integrally with the inner syringe body.

根据另一有益的进一步发展,在所述内注射器本体中特别是在其底壁中设置一个或多个通道。According to another advantageous further development, one or more channels are provided in the inner syringe body, in particular in its bottom wall.

所述一个或多个通道可以至少部分地在径向上延伸。The one or more channels may extend at least partially in a radial direction.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

在下面,将参考附图对本发明的实施方式进行详细说明。在附图中示出:In the following, embodiments of the present invention will be described in detail with reference to the accompanying drawings. In the accompanying drawings:

图1为本发明第一实施方式的注射器在起始位置的剖视图;FIG1 is a cross-sectional view of a syringe in a first embodiment of the present invention at a starting position;

图2为图1的注射器在给出第一液体或糊状物后的图;FIG2 is a diagram of the syringe of FIG1 after dispensing a first liquid or paste;

图3为图1和2的注射器在给出第二液体或糊状物后的图;FIG3 is a diagram of the syringe of FIG1 and FIG2 after dispensing a second liquid or paste;

图4为图3的放大细节图;FIG4 is an enlarged detail view of FIG3 ;

图5为本发明第二实施方式的注射器在起始位置的剖视图;FIG5 is a cross-sectional view of a syringe in a second embodiment of the present invention at a starting position;

图6为图5的注射器在给出第一液体或糊状物后的图;FIG6 is a diagram of the syringe of FIG5 after dispensing a first liquid or paste;

图7为图5和6的注射器在给出第二液体或糊状物后的图;FIG7 is a view of the syringe of FIG5 and FIG6 after dispensing a second liquid or paste;

图8为图7的放大细节图;FIG8 is an enlarged detail view of FIG7;

图9为本发明第一实施方式的改型实施方式的图,其中封套与内注射器本体形成为一体;FIG9 is a diagram of a modified embodiment of the first embodiment of the present invention, in which the envelope is formed integrally with the inner syringe body;

图10为图9的放大细节图;以及FIG10 is an enlarged detail view of FIG9; and

图11为根据图9和10的实施方式的改型的图,其中通道在内部注射器本体中在径向部分延伸。FIG. 11 is a diagram of a modification of the embodiment according to FIG. 9 and 10 , in which the channel extends radially in part in the inner syringe body.

具体实施方式DETAILED DESCRIPTION

在图1至4中所示的根据本发明第一实施方式的注射器包括外注射器本体1,内注射器本体2和活塞3。外注射器本体1包括向外引导的上缘4,护套部5,底壁6,以及给出喷口7。护套部5是圆柱形的。其具有内壁8,所述内注射器本体2沿所述内壁被纵向可移动地引导。底壁6在其中心具有给出开口9,所述给出开口被连接到在给出喷口7中的给出通道10。外注射器本体1为一体形成。The syringe according to the first embodiment of the present invention shown in Figures 1 to 4 comprises an outer syringe body 1, an inner syringe body 2 and a piston 3. The outer syringe body 1 comprises an upper edge 4 directed outward, a jacket portion 5, a bottom wall 6, and a dispensing spout 7. The jacket portion 5 is cylindrical. It has an inner wall 8 along which the inner syringe body 2 is longitudinally movably guided. The bottom wall 6 has a dispensing opening 9 at its center, which is connected to a dispensing channel 10 in the dispensing spout 7. The outer syringe body 1 is formed in one piece.

所述内注射器本体2包括护套本体11,底壁12,和封套13。护套部11是圆柱形的。其外壁沿所述外注射器本体1的护套部5的内壁8被纵向可移动地引导。为此,护套部11在其下端具有密封表面11a,所述密封表面的直径大于护套部11的剩余直径。所述密封表面11a接触内壁8。所述密封表面11a的主要功能包括,确保密封。另外,它也满足了引导作用。The inner syringe body 2 comprises a sheath body 11, a bottom wall 12, and a sleeve 13. The sheath portion 11 is cylindrical. Its outer wall is longitudinally movably guided along the inner wall 8 of the sheath portion 5 of the outer syringe body 1. To this end, the sheath portion 11 has a sealing surface 11a at its lower end, the diameter of which is greater than the remaining diameter of the sheath portion 11. The sealing surface 11a contacts the inner wall 8. The main function of the sealing surface 11a is to ensure sealing. In addition, it also fulfils a guiding function.

护套部11具有内壁14,在其中活塞3被纵向可移动地引导。通道15存在于内注射器本体2的底壁12中。通道15被均匀地分布在周边。The jacket part 11 has an inner wall 14 in which the piston 3 is guided longitudinally displaceably. Channels 15 are present in the bottom wall 12 of the inner syringe body 2. The channels 15 are evenly distributed around the circumference.

底壁12在其面向外注射器本体1的底壁6的下侧具有凸起16,封套13被插到所述凸起上。封套13以这种方式可释放地连接到凸起16。凸起16在其面向外注射器本体1的底壁6的下端区域中具有直径变大的泡起(bead)17。所述泡起17向外圆角化。护套部11,底壁12,和内注射器本体2的突起16形成为一体。The bottom wall 12 has a projection 16 on its underside facing the bottom wall 6 of the outer syringe body 1, onto which the sleeve 13 is inserted. The sleeve 13 is releasably connected to the projection 16 in this way. The projection 16 has a bead 17 with an enlarged diameter in its lower end region facing the bottom wall 6 of the outer syringe body 1. The bead 17 is rounded outward. The sheath portion 11, the bottom wall 12, and the projection 16 of the inner syringe body 2 are formed as one piece.

活塞3包括被向外引导的上缘18,活塞本体19,引导表面20和密封部21。活塞本体19具有十字形横截面。然而,其可以以不同的方式配置,并且可以特别地为圆柱形的。内注射器本体2的护套部11的内壁14的直径比活塞本体19的外径大。活塞3的引导表面20与内注射器本体2的护套部11的内壁14接触。其被在内壁14引导。密封部21密封地接触内注射器本体2的护套部11的内壁14。面向内注射器本体2的底壁12的下密封部21的直径大于面向活塞3的上缘18的上密封部21的直径。下密封部21形成主密封,上密封部21形成附加密封。The piston 3 comprises an upper edge 18 guided outwards, a piston body 19, a guiding surface 20 and a sealing portion 21. The piston body 19 has a cross-shaped cross section. However, it can be configured in a different way and can be cylindrical in particular. The diameter of the inner wall 14 of the jacket portion 11 of the inner syringe body 2 is larger than the outer diameter of the piston body 19. The guiding surface 20 of the piston 3 is in contact with the inner wall 14 of the jacket portion 11 of the inner syringe body 2. It is guided at the inner wall 14. The sealing portion 21 sealingly contacts the inner wall 14 of the jacket portion 11 of the inner syringe body 2. The diameter of the lower sealing portion 21 facing the bottom wall 12 of the inner syringe body 2 is larger than the diameter of the upper sealing portion 21 facing the upper edge 18 of the piston 3. The lower sealing portion 21 forms the main seal and the upper sealing portion 21 forms an additional seal.

在操作中,注射器首先位于图1中所示的位置。内注射器本体2的封套13与外注射器本体1的底壁6间隔开。因此形成用于第一液体或糊状物的第一体积22。活塞3下端面23与内注射器本体2的底壁12间隔开。因此形成用于第二液体或糊状物的第二体积24。During operation, the syringe is initially positioned as shown in FIG1 . The envelope 13 of the inner syringe body 2 is spaced apart from the bottom wall 6 of the outer syringe body 1 . This creates a first volume 22 for a first liquid or paste. The lower end face 23 of the piston 3 is spaced apart from the bottom wall 12 of the inner syringe body 2. This creates a second volume 24 for a second liquid or paste.

活塞3在给出过程的开始在箭头25的方向向下移动。在这方面,活塞3和内注射器本体2相对于外注射器本体1一起向下移动。体积24,通道25,以及在内注射器本体2的底壁12和封套13之间的环形空间形成被整体密封的一空间,所述空间经由密封部21和封套13密封。此被整体密封的空间,保证了由活塞3和内注射器本体2形成的单元首先相对于外注射器本体1一起向下移动。At the start of the dispensing process, the piston 3 moves downward in the direction of arrow 25. In this respect, the piston 3 and the inner syringe body 2 move downward together relative to the outer syringe body 1. The volume 24, the channel 25, and the annular space between the bottom wall 12 of the inner syringe body 2 and the envelope 13 form a space that is sealed as a whole, which is sealed via the seal 21 and the envelope 13. This space, which is sealed as a whole, ensures that the unit formed by the piston 3 and the inner syringe body 2 first moves downward together relative to the outer syringe body 1.

因此,活塞3和内注射器本体2相对于外注射器本体1一起向下移动。由此封套13朝向外注射器本体1的底壁6移动,而使第一体积22的尺寸减小,且位于所述第一体积内的第一液体或糊状物通过给出开口9和给出通道10被压出。As a result, the piston 3 and the inner syringe body 2 move downwards together relative to the outer syringe body 1. The sleeve 13 is thereby moved towards the bottom wall 6 of the outer syringe body 1, so that the size of the first volume 22 is reduced and the first liquid or paste located in the first volume is pressed out through the dispensing opening 9 and the dispensing channel 10.

这个过程一直进行直到到达在图2中所示的位置,其中封套13处于外注射器本体2中的端部位置。在该下端位置,封套13接触外注射器本体1的底壁6。This process is carried out until the position shown in Figure 2 is reached, in which the envelope 13 is in its end position in the outer syringe body 2. In this lower end position, the envelope 13 contacts the bottom wall 6 of the outer syringe body 1.

外注射器本体1在其端部区域中具有多个通道26。该通道26位于外注射器本体1的护套部5的内壁8中。所述通道始于外注射器本体1的底壁6并从该处朝上。所述通道足够长,从而在封套13处于如图2和4所示的其端部位置时它们伸出封套13的上端面之外。此外,如此设定通道26的深度尺寸使得其与封套13的外径相比在圆周方向进一步向外。所述通道26以这种方式形成绕过所述封套13而流动的路径。所述通道26均匀地分布在外注射器本体1的护套部5的周边。The outer syringe body 1 has a plurality of channels 26 in its end region. The channels 26 are located in the inner wall 8 of the jacket part 5 of the outer syringe body 1. The channels begin at the bottom wall 6 of the outer syringe body 1 and extend upwards from there. The channels are long enough so that they extend beyond the upper end face of the cuff 13 when the cuff 13 is in its end position as shown in Figures 2 and 4. In addition, the depth dimension of the channels 26 is set so that they extend further outwards in the circumferential direction than the outer diameter of the cuff 13. In this way, the channels 26 form a path for the flow around the cuff 13. The channels 26 are evenly distributed around the periphery of the jacket part 5 of the outer syringe body 1.

封套13在其下侧具有多个凹槽26a。凹槽26a在径向上延伸。它们从向内向下到向外向上延伸。凹槽26a均匀地分布在封套13的周边。凹槽26a可防止封套13的下侧完全且密封地位于给出开口9的上边界上。以这种方式,凹槽26a形成用于绕封套13流动的路径。The envelope 13 has a plurality of grooves 26a on its underside. The grooves 26a extend in a radial direction. They extend from inward and downward to outward and upward. The grooves 26a are evenly distributed around the circumference of the envelope 13. The grooves 26a prevent the underside of the envelope 13 from completely and sealingly resting on the upper boundary of the outlet opening 9. In this way, the grooves 26a form a path for flow around the envelope 13.

当注射器已经到达图2中所示的位置时,活塞3进一步向下移动。其下端面23向内注射器本体2的底壁12移动。由此使得第二体积24的尺寸减小。由于此移动,位于其中的第二液体或糊状物绕过封套13而通过通道15和通道26以及凹槽26a被压入给出开口9与给出通道10。活塞3继续移动,直到到达在图3中所示的端部位置。在所述位置,活塞3的下端面23与内注射器本体2的底壁12接触。When the syringe has reached the position shown in FIG2 , the piston 3 moves further downward. Its lower end surface 23 moves toward the bottom wall 12 of the inner syringe body 2. This causes the size of the second volume 24 to decrease. Due to this movement, the second liquid or paste located therein bypasses the envelope 13 and is pressed into the dispensing opening 9 and the dispensing channel 10 through the channels 15 and 26 and the groove 26a. The piston 3 continues to move until it reaches the end position shown in FIG3 . In this position, the lower end surface 23 of the piston 3 contacts the bottom wall 12 of the inner syringe body 2.

在图5至8中示出的根据本发明的第二实施方式的注射器中,其中相同的部件设置有相同的参考标号,将不会再次描述。在这里,外注射器本体1在其端部区域具有腹板27。腹板27与外注射器本体1的底壁6连接。所述腹板27从底壁6朝向封套13向上突出。腹板27与底壁6连接成一体。腹板27从向下向内朝向向外向上。腹板27被均匀地分布在周边。在本实施方式中存在六个腹板27。In the syringe according to the second embodiment of the invention shown in Figures 5 to 8, in which identical parts are provided with the same reference numerals, no further description will be given. Here, the outer syringe body 1 has a web 27 in its end region. The web 27 is connected to the bottom wall 6 of the outer syringe body 1. The web 27 protrudes upward from the bottom wall 6 toward the envelope 13. The web 27 is integrally connected to the bottom wall 6. The web 27 extends from downward to inward toward outward to upward. The webs 27 are evenly distributed around the periphery. In this embodiment, there are six webs 27.

抬高部28存在于两个腹板27之间。它们向上朝向,即朝向封套13。抬高部28位于在外注射器本体1的底壁6中的给出开口9的附近。抬高部28均匀地分布在周边。由抬高部28形成用于封套13的拱座。Between the two webs 27 there are raised portions 28. They face upwards, i.e. towards the envelope 13. The raised portions 28 are located near the dispensing opening 9 in the bottom wall 6 of the outer syringe body 1. The raised portions 28 are evenly distributed around the circumference. The raised portions 28 form an abutment for the envelope 13.

封套13是可变形的。它至少可在其外部区域中变形。当封套13被移向在图6,7,和8中示的其端部位置时,其外部区域被腹板27向上,也就是朝向内注射器本体2的底壁12,变形。封套13的外缘因此从外注射器本体1的内壁8离开。封套13因此不再密封地接触内壁8。其可在腹板27之间的区域被第二液体或糊状物绕流。The envelope 13 is deformable. It is deformable at least in its outer region. When the envelope 13 is moved toward its end position shown in Figures 6, 7, and 8, its outer region is deformed upward by the webs 27, that is, toward the bottom wall 12 of the inner syringe body 2. The outer edge of the envelope 13 is thus separated from the inner wall 8 of the outer syringe body 1. The envelope 13 is therefore no longer in sealing contact with the inner wall 8. The second liquid or paste can flow around it in the area between the webs 27.

封套13朝向底壁6的路径由抬高部28限定,所述抬高部28形成封套13的下端面的拱座。因此保证了封套13的下端面不完全接触给出开口9的上边界,从而使得第二液体或糊状物可以从底壁6的区域流出,经过封套13的下端面而进入给出开口9。The path of the envelope 13 towards the bottom wall 6 is defined by the raised portion 28, which forms an abutment for the lower end face of the envelope 13. This ensures that the lower end face of the envelope 13 does not completely contact the upper boundary of the dispensing opening 9, so that the second liquid or paste can flow out from the area of the bottom wall 6, pass through the lower end face of the envelope 13 and enter the dispensing opening 9.

本发明所提供的双组分注射器(也被称为2C注射器)可将两种不同的组分依序给出。这两种不同的组分被单独地存储在2C注射器中,即其体积22和24中。它们不会混合或相互影响。The two-component syringe (also referred to as a 2C syringe) provided by the present invention can give two different components in sequence. The two different components are stored separately in the 2C syringe, i.e., in its volumes 22 and 24. They will not mix or affect each other.

在操作中,通过按压活塞3使注射器2C的内注射器本体2在外注射器本体1中移动,由此,第一组分通过给出喷口7的给出通道10被压出。如图2和6所示,当第一组分已完全被从外注射器本体1压出时,内注射器本体2处于外注射器本体1中的端部位置。根据图1至4的第一实施方式,在此端部位置,封套在外注射器本体1中被通道26露出。第二组分可以流过内注射器本体2的通道15并流过外注射器本体1中的通道26,而可通过给出通道10被压入给出喷口7。During operation, the inner syringe body 2 of the syringe 2C is moved in the outer syringe body 1 by pressing the piston 3, whereby the first component is pressed out through the dispensing channel 10 of the dispensing spout 7. As shown in Figures 2 and 6, when the first component has been completely pressed out of the outer syringe body 1, the inner syringe body 2 is in the end position in the outer syringe body 1. According to the first embodiment of Figures 1 to 4, in this end position, the envelope is exposed in the outer syringe body 1 by the channel 26. The second component can flow through the channel 15 of the inner syringe body 2 and through the channel 26 in the outer syringe body 1, and can be pressed into the dispensing spout 7 through the dispensing channel 10.

在根据图5至8的第二实施方式中,封套13的端部位置可在外注射器本体1中通过可形成为腹板的抬高部28形成。在外注射器本体1和封套13之间由抬高部28或腹板形成相应的自由空间或通道。在此端部位置,封套13经由外注射器本体中的1腹板27变形,使得它泄漏。第二组分然后可移过内注射器本体2的通道15和经过变形的泄露的封套13而进入外注射器本体1内,并通过给出喷口7被压出。In the second embodiment according to Figures 5 to 8, the end position of the envelope 13 can be formed in the outer syringe body 1 by a raised portion 28, which can be formed as a web. A corresponding free space or channel is formed between the outer syringe body 1 and the envelope 13 by the raised portion 28 or web. In this end position, the envelope 13 is deformed by the web 27 in the outer syringe body, causing it to leak. The second component can then move through the channel 15 of the inner syringe body 2 and through the deformed, leaking envelope 13 into the outer syringe body 1 and be expelled through the dispensing spout 7.

图9和10示出了根据图1至4的第一实施方式的改型,其中,封套13与内注射器本体2形成为一体。9 and 10 show a modification of the first embodiment according to FIGS. 1 to 4 , in which the envelope 13 is formed in one piece with the inner syringe body 2 .

在根据图11的另一改型中,封套13同样与内注射器本体2形成为一体。这里,通道15具有共同部15和从体积24到内注射器本体2的底壁12和封套13之间的环形间隙的径向部15′。共同部15位于底壁12的中心。在这里其在轴向上向下延伸。径向部15′在径向上从共同部15的下端向外延伸至所述环形间隙。根据图11的实施方式也可用于当封套13可释放地连接到内注射器本体2时的情况。In another variant according to FIG11 , the envelope 13 is likewise formed integrally with the inner syringe body 2. Here, the channel 15 comprises a common portion 15 and a radial portion 15′ extending from the volume 24 to the annular gap between the bottom wall 12 of the inner syringe body 2 and the envelope 13. The common portion 15 is located in the center of the bottom wall 12. Here, it extends axially downwards. The radial portion 15′ extends radially outwards from the lower end of the common portion 15 to the annular gap. The embodiment according to FIG11 can also be used in the case where the envelope 13 is releasably connected to the inner syringe body 2.

Claims (12)

1.一种用于给出第一和第二液体或糊状物的注射器,包括外注射器本体(1),在所述外注射器本体中,内注射器本体(2)被纵向可移位地引导,在所述内注射器本体中,活塞(3)被纵向可移位地引导,1. A syringe for dispensing first and second liquids or pastes, comprising an outer syringe body (1) in which an inner syringe body (2) is longitudinally displaceable, and in which a piston (3) is longitudinally displaceable. 其特征在于,Its features are, 所述内注射器本体(2)具有护套本体(11)、底壁(12)和封套(13),所述封套(13)密封地接触所述外注射器本体(1)的内壁(8),并且当其位于外注射器本体(1)中的端部位置时,所述第二液体或糊状物可绕过其流动,所述外注射器本体(1)在其端部区域中具有的一个或多个通道(26),所述封套(13)在其下侧具有一个或多个凹槽(26a),The inner syringe body (2) has a sheath body (11), a bottom wall (12), and a cover (13), the cover (13) sealingly contacting the inner wall (8) of the outer syringe body (1), and the second liquid or paste can flow around it when it is in the end position in the outer syringe body (1), the outer syringe body (1) having one or more channels (26) in its end region, and the cover (13) having one or more grooves (26a) on its underside. 所述护套本体(11)是圆柱形的,并且在其下端具有密封表面(11a),所述密封表面的直径大于护套本体(11)的剩余直径,所述密封表面(11a)接触内壁(8),其中至少一个通道形成在所述内注射器本体(2)的底壁中,连接所述内注射器本体(2)的内部与所述内注射器本体(2)的所述底壁(12)和所述封套(13)之间的环形空间。The sheath body (11) is cylindrical and has a sealing surface (11a) at its lower end. The diameter of the sealing surface is larger than the remaining diameter of the sheath body (11). The sealing surface (11a) contacts the inner wall (8). At least one channel is formed in the bottom wall of the inner syringe body (2) to connect the interior of the inner syringe body (2) with the annular space between the bottom wall (12) of the inner syringe body (2) and the sheath (13). 2.根据权利要求1所述的注射器,其特征在于,在所述外注射器本体(1)的底壁(6)内具有抬高部(28)。2. The syringe according to claim 1, characterized in that it has a raised portion (28) in the bottom wall (6) of the outer syringe body (1). 3.根据权利要求1或2所述的注射器,其特征在于,所述封套(13)可释放地连接到所述内注射器本体(2)。3. The syringe according to claim 1 or 2, wherein the sleeve (13) is releasably connected to the inner syringe body (2). 4.根据权利要求1或2所述的注射器,其特征在于,所述封套(13)与所述内注射器本体(2)形成为一体。4. The syringe according to claim 1 or 2, wherein the sleeve (13) is integrally formed with the inner syringe body (2). 5.根据权利要求1或2所述的注射器,其特征在于,第一和第二液体或糊状物是药物。5. The syringe according to claim 1 or 2, wherein the first and second liquids or pastes are drugs. 6.根据权利要求5所述的注射器,其特征在于,形成在所述内注射器本体(2)的底壁中的所述通道至少部分地在径向上延伸。6. The syringe according to claim 5, wherein the channel formed in the bottom wall of the inner syringe body (2) extends at least partially in the radial direction. 7.一种用于给出第一和第二液体或糊状物的注射器,包括外注射器本体(1),在所述外注射器本体中,内注射器本体(2)被纵向可移位地引导,在所述内注射器本体中,活塞(3)被纵向可移位地引导,7. A syringe for dispensing first and second liquids or pastes, comprising an outer syringe body (1) in which an inner syringe body (2) is longitudinally displaceable, and in which a piston (3) is longitudinally displaceable. 其特征在于,Its features are, 所述内注射器本体(2)具有护套本体(11)、底壁(12)和封套(13),所述封套(13)密封地接触所述外注射器本体(1)的内壁(8),并且当其位于外注射器本体(1)中的端部位置时,所述第二液体或糊状物可绕过其流动,所述封套(13)在外注射器本体(1)中的端部位置处能够通过在所述外注射器本体(1)的端部区域内的腹板(27)变形,使得当所述封套(13)位于外注射器本体(1)中的端部位置时可绕过所述封套(13)流动,The inner syringe body (2) has a sheath body (11), a bottom wall (12), and a sleeve (13), the sleeve (13) sealingly contacting the inner wall (8) of the outer syringe body (1), and the second liquid or paste can flow around it when it is located at the end position in the outer syringe body (1). The sleeve (13) at the end position in the outer syringe body (1) can be deformed by the web (27) in the end region of the outer syringe body (1), so that the flow can bypass the sleeve (13) when the sleeve (13) is located at the end position in the outer syringe body (1). 所述护套本体(11)是圆柱形的,并且在其下端具有密封表面(11a),所述密封表面的直径大于护套本体(11)的剩余直径,所述密封表面(11a)接触内壁(8),其中至少一个通道形成在所述内注射器本体(2)的底壁中,连接所述内注射器本体(2)的内部与所述内注射器本体(2)的所述底壁(12)和所述封套(13)之间的环形空间。The sheath body (11) is cylindrical and has a sealing surface (11a) at its lower end. The diameter of the sealing surface is larger than the remaining diameter of the sheath body (11). The sealing surface (11a) contacts the inner wall (8). At least one channel is formed in the bottom wall of the inner syringe body (2) to connect the interior of the inner syringe body (2) with the annular space between the bottom wall (12) of the inner syringe body (2) and the sheath (13). 8.根据权利要求7所述的注射器,其特征在于,在所述外注射器本体(1)的底壁(6)内具有抬高部(28)。8. The syringe according to claim 7, characterized in that it has a raised portion (28) in the bottom wall (6) of the outer syringe body (1). 9.根据权利要求7或8所述的注射器,其特征在于,所述封套(13)可释放地连接到所述内注射器本体(2)。9. The syringe according to claim 7 or 8, wherein the sheath (13) is releasably connected to the inner syringe body (2). 10.根据权利要求7或8所述的注射器,其特征在于,所述封套(13)与所述内注射器本体(2)形成为一体。10. The syringe according to claim 7 or 8, wherein the sleeve (13) is integrally formed with the inner syringe body (2). 11.根据权利要求7或8所述的注射器,其特征在于,第一和第二液体或糊状物是药物。11. The syringe according to claim 7 or 8, wherein the first and second liquids or pastes are drugs. 12.根据权利要求11所述的注射器,其特征在于,形成在所述内注射器本体(2)的底壁中的所述通道至少部分地在径向上延伸。12. The syringe according to claim 11, wherein the channel formed in the bottom wall of the inner syringe body (2) extends at least partially in the radial direction.
HK16111925.9A 2014-12-05 2016-10-15 Injector for administering a liquid or pasty substance, in particular a drug HK1223580B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE102014018077.8 2014-12-05
DE102014018077 2014-12-05
DE102015002234.2A DE102015002234A1 (en) 2014-12-05 2015-02-19 Injector for dispensing a liquid or pasty substance, in particular medicament
DE102015002234.2 2015-02-19
EP15175696.2 2015-07-07
EP15175696.2A EP3028729B1 (en) 2014-12-05 2015-07-07 Injector for dispensing a liquid or paste substance, in particular a medicament

Publications (2)

Publication Number Publication Date
HK1223580A1 HK1223580A1 (en) 2017-08-04
HK1223580B true HK1223580B (en) 2021-11-05

Family

ID=

Similar Documents

Publication Publication Date Title
US9962492B2 (en) Syringe assembly
US9636463B2 (en) Combination container/syringe
CN107205843B (en) Universal syringe platform
JP2930201B2 (en) Stopper assembly with bypass for use in a multi-chamber syringe barrel
JPH1080485A (en) Continuous operation stopper
EP2444110B1 (en) Dual chamber combined container-syringe
KR102372700B1 (en) Prefilled syringe
JP2017509466A5 (en)
JP6763772B2 (en) Devices and methods for small volume drug delivery
US20180078701A1 (en) Valved container assembly
CN105664300B (en) Syringe for administering liquids or pastes, in particular medicaments
HK1223580B (en) Injector for administering a liquid or pasty substance, in particular a drug
JP2006297100A (en) Dosing apparatus with protected priming device
KR102715085B1 (en) Dual chamber syringe
EP0728492B1 (en) Dual chamber internal by-pass syringe assembly
KR20250148728A (en) Prefilled syringe with built-in filter